IL232194A0 - Improved cross-linking composition deliverd by inotophoresis, useful for the treatment of keratoconus - Google Patents
Improved cross-linking composition deliverd by inotophoresis, useful for the treatment of keratoconusInfo
- Publication number
- IL232194A0 IL232194A0 IL232194A IL23219414A IL232194A0 IL 232194 A0 IL232194 A0 IL 232194A0 IL 232194 A IL232194 A IL 232194A IL 23219414 A IL23219414 A IL 23219414A IL 232194 A0 IL232194 A0 IL 232194A0
- Authority
- IL
- Israel
- Prior art keywords
- inotophoresis
- deliverd
- keratoconus
- useful
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000560A ITRM20110560A1 (en) | 2011-10-25 | 2011-10-25 | IMPROVED CROSS-LINKING COMPOSITION FOR THE TREATMENT OF KERATOCONUS BY IONTOFORESIS |
| PCT/IT2012/000324 WO2013061350A1 (en) | 2011-10-25 | 2012-10-24 | Improved cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL232194A0 true IL232194A0 (en) | 2014-06-30 |
| IL232194A IL232194A (en) | 2016-09-29 |
Family
ID=45315962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL232194A IL232194A (en) | 2011-10-25 | 2014-04-22 | Cross-linking composition deliverd by inotophoresis, useful for the treatment of keratoconus |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9439908B2 (en) |
| EP (1) | EP2770979B1 (en) |
| JP (1) | JP5913606B2 (en) |
| KR (1) | KR101837238B1 (en) |
| AU (1) | AU2012327916B2 (en) |
| BR (1) | BR112014009761B8 (en) |
| CA (1) | CA2851331C (en) |
| EA (1) | EA026703B1 (en) |
| ES (1) | ES2546263T3 (en) |
| IL (1) | IL232194A (en) |
| IN (1) | IN2014CN02972A (en) |
| IT (1) | ITRM20110560A1 (en) |
| MX (1) | MX342930B (en) |
| PT (1) | PT2770979E (en) |
| RS (1) | RS54139B1 (en) |
| WO (1) | WO2013061350A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9622911B2 (en) | 2010-09-30 | 2017-04-18 | Cxl Ophthalmics, Llc | Ophthalmic treatment device, system, and method of use |
| ES2590127T3 (en) | 2011-01-12 | 2016-11-18 | Sooft Italia S.P.A. | Corneal administration of iontophoresis crosslinking agents for the treatment of keratoconus and related ophthalmic compositions |
| US9566301B2 (en) | 2012-03-29 | 2017-02-14 | Cxl Ophthalmics, Llc | Compositions and methods for treating or preventing diseases associated with oxidative stress |
| EP2830627B1 (en) | 2012-03-29 | 2024-05-01 | Epion Therapeutics, Inc. | Ocular treatment solutions, delivery devices and delivery augmentation methods |
| US9931199B2 (en) * | 2014-05-05 | 2018-04-03 | Roberto Gustavo ALBERTAZZI | Methods and apparatus for treating keratoconus |
| JP6933377B2 (en) | 2015-07-21 | 2021-09-08 | アヴェドロ・インコーポレーテッドＡｖｅｄｒｏ，Ｉｎｃ． | Eye treatment systems and methods using photosensitizers |
| WO2017180851A1 (en) | 2016-04-13 | 2017-10-19 | Avedro, Inc. | Systems and methods for delivering drugs to an eye |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030023228A1 (en) * | 2001-07-20 | 2003-01-30 | Parkinson Thomas M. | Ocular iontophoretic device and method for using the same |
| ITRM20070356A1 (en) * | 2007-06-26 | 2008-12-27 | Sooft Italia Srl | STERILE OCULAR SOLUTION DISPOSABLE AND ITS PRODUCTION PROCEDURE FOR THE CORNEAL CROSS LINKING OF THE KERATOCONO |
| IT1393402B1 (en) * | 2008-08-28 | 2012-04-20 | Sooft Italia Spa | USE OF ENHANCER EVENTUALLY WITH RIBOFLAVIN, AS WELL AS RELATIVE OPHTHALMIC COMPOSITIONS FOR CORNEAL CROSS-LINKING OF KERATOCON OR OTHER ECNEASIC CORNEAL PATHOLOGIES |
| EP2289937A1 (en) | 2009-08-24 | 2011-03-02 | Wilfried Stücker | Production of monoclonal antibodies in vitro |
| WO2011130356A2 (en) * | 2010-04-13 | 2011-10-20 | Avedro, Inc. | Systems and methods for activating cross-linking in an eye |
-
2011
- 2011-10-25 IT IT000560A patent/ITRM20110560A1/en unknown
-
2012
- 2012-10-24 AU AU2012327916A patent/AU2012327916B2/en active Active
- 2012-10-24 JP JP2014537816A patent/JP5913606B2/en not_active Expired - Fee Related
- 2012-10-24 PT PT128135340T patent/PT2770979E/en unknown
- 2012-10-24 MX MX2014004297A patent/MX342930B/en active IP Right Grant
- 2012-10-24 US US14/353,872 patent/US9439908B2/en active Active
- 2012-10-24 RS RS20150504A patent/RS54139B1/en unknown
- 2012-10-24 KR KR1020147013678A patent/KR101837238B1/en active IP Right Grant
- 2012-10-24 IN IN2972CHN2014 patent/IN2014CN02972A/en unknown
- 2012-10-24 CA CA2851331A patent/CA2851331C/en active Active
- 2012-10-24 ES ES12813534.0T patent/ES2546263T3/en active Active
- 2012-10-24 BR BR112014009761A patent/BR112014009761B8/en active IP Right Grant
- 2012-10-24 EA EA201490845A patent/EA026703B1/en not_active IP Right Cessation
- 2012-10-24 EP EP12813534.0A patent/EP2770979B1/en active Active
- 2012-10-24 WO PCT/IT2012/000324 patent/WO2013061350A1/en active Application Filing
-
2014
- 2014-04-22 IL IL232194A patent/IL232194A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP2770979A1 (en) | 2014-09-03 |
| MX342930B (en) | 2016-10-19 |
| MX2014004297A (en) | 2014-07-24 |
| US9439908B2 (en) | 2016-09-13 |
| IL232194A (en) | 2016-09-29 |
| ITRM20110560A1 (en) | 2013-04-26 |
| AU2012327916A1 (en) | 2014-05-22 |
| WO2013061350A1 (en) | 2013-05-02 |
| JP2014530904A (en) | 2014-11-20 |
| US20140303173A1 (en) | 2014-10-09 |
| RS54139B1 (en) | 2015-12-31 |
| CN104023706A (en) | 2014-09-03 |
| EP2770979B1 (en) | 2015-07-08 |
| KR101837238B1 (en) | 2018-03-09 |
| BR112014009761B1 (en) | 2022-05-24 |
| KR20140080553A (en) | 2014-06-30 |
| IN2014CN02972A (en) | 2015-07-03 |
| ES2546263T3 (en) | 2015-09-22 |
| EA201490845A1 (en) | 2014-07-30 |
| JP5913606B2 (en) | 2016-04-27 |
| PT2770979E (en) | 2015-10-07 |
| BR112014009761A2 (en) | 2017-04-25 |
| CA2851331C (en) | 2019-11-12 |
| CA2851331A1 (en) | 2013-05-02 |
| AU2012327916B2 (en) | 2016-04-21 |
| BR112014009761B8 (en) | 2022-09-06 |
| EA026703B1 (en) | 2017-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE041685T2 (en) | Composition including 2,3,3,3-tetrafluoropropene | |
| PL2791093T3 (en) | Process for the preparation of 2, 3, 3, 3 tetrafluoropropene | |
| HK1201042A1 (en) | Compositions for the treatment of dry eye | |
| EP2812298A4 (en) | Improved process for the manufacture of 2,3,3,3-tetrafluoropropene | |
| EP2762476A4 (en) | 1,2,4-triazine-6-carboxamide derivative | |
| EP2699091A4 (en) | 2',6'-dioxo-3'-deutero-piperdin-3-yl-isoindoline compounds | |
| IL232194A0 (en) | Improved cross-linking composition deliverd by inotophoresis, useful for the treatment of keratoconus | |
| AP2014007399A0 (en) | Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament | |
| HK1192757A1 (en) | Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines 4--n--135--2- | |
| EP2675773A4 (en) | Process for cis-1-chloro-3,3,3,trifluoropropene | |
| HK1206938A1 (en) | Process for the preparation of 3-chloro-4,5,6-trifluoro- picolinonitrile 3--456-- | |
| EP2937326A4 (en) | 1, 3, 3, 3-tetrafluoropropene preparation process | |
| HK1201150A1 (en) | Scheme for administering n-hydroxy-4-2-[3-(n,n- dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxybenzamide n--4-2-[3-(n,n-)-2-] | |
| HK1207317A1 (en) | Substituted 1,6-naphthyridines 16- | |
| EP2794806A4 (en) | Azeotrope-like compositions including cis-1-chloro-3,3,3-trifluoropropene | |
| EP2730555A4 (en) | Composition containing 1,4-butanediol | |
| HK1200109A1 (en) | Ophthalmic composition | |
| EP2814797A4 (en) | Process for 1,3,3,3-tetrafluoropropene | |
| HK1200113A1 (en) | Ophthalmic composition | |
| PL2851075T3 (en) | Preparation containing 6,7-unsaturated-7-carbamoylmorphinan derivative | |
| SG11201501289TA (en) | Preparation for preventing or treating type i diabetes | |
| PL2768527T3 (en) | Multi-cbv vaccine for preventing or treating type 1 diabetes | |
| IL229669A0 (en) | Process for preparation of 1,2,3 -triazole-4-carboxamides | |
| PL2734492T3 (en) | Process for the preparation of 1, 1, 1 - trifluoropropane | |
| EP2800573A4 (en) | Ophthalmic composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |